Leveraging the Emergency Department (LEAD) Study

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorHackensack Meridian Health

About this trial

This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.

Eligibility criteria

Qualifiers

Aged 50 years to 80 years

Currently smoke cigarettes or quit smoking cigarettes within the past 15 years

20 pack-year smoking history

Has never had lung cancer screening

Disqualifiers

Diagnosed with lung cancer

Has a history of having a lung cancer screening scan

Unable to speak and understand English

Trial design

Treatments tested in this trial

  • LungTalk
  • Non-tailored lung screening

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hackensack Meridian Health

Lead sponsor

New Jersey Commission on Cancer Research

Collaborator